Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
Vaccines
vax-SPIRAL®
Trivalent Antileptospirosis Vaccine
https://www.finlay.edu.cu/wp-content/uploads/2015/11/vax-SPIRAL.jpg 
Its use is recommended in people from 15 years of age, whose occupational profile exposes them to risks of acquiring the disease.
vax-MEN-AC®
Polymencharide Antimeningococcal Vaccine A & C
https://www.finlay.edu.cu/wp-content/uploads/2015/11/vax-MEN-AC.jpg 
For active immunization against meningococcal disease caused by serogroups A and C, in adults and children from two years of age.
vax-TET®
Tetanus Vaccine
https://www.finlay.edu.cu/wp-content/uploads/2015/11/vax-TET.jpg 
It is recommended for the prevention of tetanus in all ages.
vax-TyVi®
Viral Polysaccharide Antithyroid Vaccine
https://www.finlay.edu.cu/wp-content/uploads/2015/11/vax-TyVi.jpg 
Prevents typhoid fever in adults and children over 2 years of age.
diTe-vax®
Diphtheria-tetanus Vaccine
https://www.finlay.edu.cu/wp-content/uploads/2015/11/dite-vax.jpg 
Indicated for the prevention of tetanus and diphtheria in adults, adolescents and children from 7 years of age.
DTP-VAX®
Diphtheria-tetanus-anti-pertussis vaccine
https://www.finlay.edu.cu/wp-content/uploads/2015/11/DTP-VAX.jpg 
It is indicated for the prevention of tetanus, diphtheria and pertussis in infants and children.
VA-DIFTET®
Diphtheria-Tetanus Vaccine
https://www.finlay.edu.cu/wp-content/uploads/2015/11/VA-DIFTET.jpg 
Effective to prevent tetanus and diphtheria if a complete and appropriate vaccination is achieved.
VA-MENGOC-BC®
BC Meningococcal Vaccine
https://www.finlay.edu.cu/wp-content/uploads/2015/11/VA-MENGOC-BC.jpg 
For active immunization against meningococcal disease caused by serogroups B and C.
Proyects
Clinical trials.
Attenuated vaccine against cholera (CV638)
I+D
Multivalent vaccine against meningococcal disease
Clinical trials.
Conjugated vaccine against Streptococcus pneumoniae
I+D
Conjugated vaccine against typhoid fever
IFAs
Purified polysaccharide from Neisseria meningitis serogroup C
Purified polysaccharide from Neisseria meningitis serogroup A
Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
Purified capsular polysaccharide Vi from Salmonella Typhi
Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
Inactivated cells of Bordetella Pertussis
Active pharmaceutical ingredient for the manufacture of vaccines.
2L Bottle
Sterile Purified Diphtheria Anatoxin (ADPE)
Active pharmaceutical ingredient for the manufacture of vaccines.
2L Bottle
Sterile Purified Tetanus Anatoxin (ATPE)
Active pharmaceutical ingredient for the manufacture of vaccines.
2L Bottle
Purified polysaccharide from Neisseria meningitis serogroup W135
Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
External membrane vesicles of Neisseria meningitis B
Active pharmaceutical ingredient for vaccine manufacturing.
500 mL Bottle